Immunomodulating cancer treatments

inflammatory

Focus on advancing immunomodulating cancer treatments – Christian Doppler Laboratory for Personalized Immunotherapy opened at MedUni Vienna: The interactions between cancer tissue and a patient’s individual immune system are part of a complex and hitherto insufficiently understood interplay. However, a thorough understanding of this complex orchestration of activating and suppressing signals is essential as a […]

Read More… from Immunomodulating cancer treatments

How stress can stop immune cells in their tracks

burnout

How stress can stop immune cells in their tracks: Researchers have discovered that signals produced by nerves in response to stress can stop immune cells from effectively fighting pathogens or tumours. Led by University of Melbourne Professor Scott Mueller, Laboratory Head at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), the study made the […]

Read More… from How stress can stop immune cells in their tracks

Loneliness in men linked to cancer risk

Loneliness

Loneliness in men linked to cancer risk: A recent study by the University of Eastern Finland shows that loneliness among middle-aged men is associated with an increased risk of cancer. According to the researchers, taking account of loneliness and social relationships should thus be an important part of comprehensive health care and disease prevention. The […]

Read More… from Loneliness in men linked to cancer risk

Urine test could reduce invasive cancer biopsies

urine

Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is. A new study published today shows how an experimental new test called ‘ExoGrail‘ has the potential to revolutionise how patients with suspected prostate cancer are risk-assessed prior to an invasive biopsy. […]

Read More… from Urine test could reduce invasive cancer biopsies

Health checks men must start today

health checks

Health checks men must start today : It’s more important than ever to safeguard your health, and fortunately there are a few health checks every man must do. Recent research from Bupa revealed: One in four (24%) men have never checked themselves for testicular cancer With nearly half (45%) admitting they ‘regularly forget’ to look for […]

Read More… from Health checks men must start today

Endocrine disruptors and breast cancer risk

endocrine disruptors

Review summarizes known links between endocrine disruptors and breast cancer risk: Exposure to certain endocrine-disrupting chemicals could elevate the risk of breast cancer, according to a new comprehensive systematic review of epidemiological research. However, for many chemicals, evidence is inconsistent or still limited. The review was carried out by researchers at the universities of Hong […]

Read More… from Endocrine disruptors and breast cancer risk

UK Covid-19: Cancer patients more likely to die

UK

Cancer patients from the UK were 1.5 times more likely to die following a diagnosis with COVID-19 than cancer patients from European countries. This is the finding of a study of over 1000 patients – 924 from European countries and 468 from the UK – during the first wave of the COVID-19 pandemic. The research […]

Read More… from UK Covid-19: Cancer patients more likely to die

First Patient in Historic First-in-Human Clinical Trial for Glioblastoma

first

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, has announced the dosing of its first patient in a first-in-human Phase 0 clinical trial of sonodynamic therapy (SDT), a non invasive drug-device combination developed by SonALAsense in collaboration with Insightec. This historic study aims to develop […]

Read More… from First Patient in Historic First-in-Human Clinical Trial for Glioblastoma

ProFound AI May Reduce Interval Breast Cancer Rates

AI May Reduce Interval Breast Cancer Rates

New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates: Retrospective analysis published in Journal of Medical Screening suggests that ProFound AI for 2D Mammography could have helped detect 48% of interval cancers and 93% of subgroups that include false-negatives and minimal sign lesions. NASHUA, N.H. – March 31, 2021 – iCAD, Inc. (NASDAQ: ICAD), […]

Read More… from ProFound AI May Reduce Interval Breast Cancer Rates